Invesco Pharmaceuticals ETF
PJP
PJP
97 hedge funds and large institutions have $344M invested in Invesco Pharmaceuticals ETF in 2014 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 37 increasing their positions, 27 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
17% more capital invested
Capital invested by funds: $293M → $344M (+$51M)
8% more funds holding
Funds holding: 90 → 97 (+7)
0.27% less ownership
Funds ownership: 23.51% → 23.24% (-0.27%)
Holders
97
Holding in Top 10
7
Calls
$2.27M
Puts
$738K
Top Buyers
| 1 | +$11.2M | |
| 2 | +$5.4M | |
| 3 | +$5.35M | |
| 4 |
SCM
Summit Capital Management
Seattle,
Washington
|
+$4.84M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$4.56M |
Top Sellers
| 1 | -$6.37M | |
| 2 | -$2.43M | |
| 3 | -$1.9M | |
| 4 |
Goldman Sachs
New York
|
-$1.8M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.72M |